Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

105.47 +2.75 (+2.67%)
Streaming Delayed Price Updated: 10:29 AM EDT, Jul 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,758,594
Open 102.65
Bid (Size) 105.45 (1)
Ask (Size) 105.48 (2)
Prev. Close 102.72
Today's Range 102.50 - 105.60
52wk Range 89.67 - 121.64
Shares Outstanding 1,750,942,289
Dividend Yield 1.93%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Dow Closes At New High As Q2 Earnings Season Heats Up
It’s a great start to the trading week. After months of trailing its major-index brethren, the Dow Jones reaches today’s closing bell at a new record high: 40,211. Q2 earnings are coming in well so... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Netflix, Goldman Sachs, J&J, ASML Lead Q2 Reports This Week As Analysts See Earnings Growth Accelerating To Fastest In Over 2 Years
Following a lackluster big bank earnings, market participants now turn their attention to the unfolding week, expecting the trend to reverse. 
Via Benzinga

Performance

YTD
-3.99%
-3.99%
1 Month
+1.95%
+1.95%
3 Month
-3.43%
-3.43%
6 Month
-7.29%
-7.29%
1 Year
-1.43%
-1.43%

More News

Read More
The 7 Most Undervalued Healthcare Stocks to Buy in July 2024
Via InvestorPlace
Looking Into Abbott Laboratories's Recent Short Interest
Via Benzinga
7 Analysts Have This To Say About Abbott Laboratories
Via Benzinga
Market Whales and Their Recent Bets on ABT Options
Via Benzinga
U.S. Cannabis Market Soars Amid Legal Reforms, But Safety Concerns Persist
From Financial Buzz Media
Via GlobeNewswire
7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns
Via InvestorPlace
Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
The 3 Best Healthcare Stocks to Buy in July 2024
Via InvestorPlace
AbbVie Stock: A Perfect Dip for Investors to Buy
Via MarketBeat
Topics ETFs
Abbott Laboratories's Options: A Look at What the Big Money is Thinking
Via Benzinga
7 Dividend Aristocrats That Will Have Investors in High-Yield Heaven
Via InvestorPlace
Topics Stocks
Exposures US Equities
3 MedTech Stocks to Buy for Healthy Gains
Via InvestorPlace
Stocks Going Ex Dividend In July 2024
Via Talk Markets
Hot Summer Dividends: 3 Sizzling Stocks to Buy for Reliable Income
Via InvestorPlace
Top Analyst Reports For Abbott, BP & Gilead
Via Talk Markets
10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year
Via The Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
Via The Motley Fool
2 Healthcare Stocks to Buy Hand Over Fist in June
Via The Motley Fool
2 Magnificent Dividend Growth Stocks to Buy Now
Via The Motley Fool
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
Via Investor's Business Daily
Exposures Product Safety
Class Action Against Abbott's Glucerna Products Proceeds in Federal Court
Via Benzinga
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
Copyright © 1995-2016 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.